AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular

Weijing Cai1, Massimo Torreggiani, Li Zhu

  • 1Division of Experimental Diabetes and Aging, Mount Sinai School of Medicine, Box 1640, One Gustave Levy Place, New York, NY 10029, USA.

Insights

Advanced glycated end-product receptor 1 (AGER1) prevents vascular damage by inhibiting reactive oxygen species (ROS). This study clarifies how specific advanced glycated end products (AGEs) trigger ROS via NADPH oxidase, with AGER1 offering protection.

Area of Science:

  • Molecular Biology
  • Vascular Biology
  • Oxidative Stress Research

Background:

  • Advanced glycated end-product receptor 1 (AGER1) is known to protect against vascular disease by inhibiting reactive oxygen species (ROS).
  • The precise advanced glycated end products (AGEs), their sources, and the specific pathways through which they promote ROS generation remain incompletely understood.

Purpose of the Study:

  • To elucidate the mechanism of NADPH oxidase (NOX)-dependent ROS generation induced by specific AGEs (N(epsilon)-carboxymethyl-lysine and methylglyoxal-modified BSA).
  • To investigate the role of AGER1 in modulating AGE-induced ROS production in human aortic endothelial cells and in vivo mouse models.

Main Methods:

  • Assessed NOX activity, superoxide anion production, and NF-kappaB p65 nuclear translocation in AGER1-overexpressing and AGER1-knockdown endothelial cells exposed to defined AGEs.
  • Utilized human aortic endothelial cells (EC), ECV304 cells, and aortic segments from aged mice on low-AGE or AGE-supplemented diets.
  • Examined epidermal growth factor receptor (EGFR)-dependent PKC-delta phosphorylation at Tyr-311 and Tyr-332.

Main Results:

  • Wild-type and AGER1-knockdown cells, but not AGER1-overexpressing cells, exhibited increased NOX activity, superoxide anions, and NF-kappaB p65 translocation in response to AGEs.
  • AGE-induced ROS generation involved EGFR-dependent, redox-sensitive phosphorylation of PKC-delta, which was suppressed by AGER1 overexpression and enhanced by AGER1 knockdown.
  • Aged mice on an AGE-supplemented diet showed significantly elevated aortic ROS, PKC-delta phosphorylation, NOX expression, and nuclear p65 compared to controls, with lower AGER1 levels.

Conclusions:

  • Circulating AGEs stimulate NADPH-dependent ROS generation, contributing to vascular aging through pathways involving NOX activation and PKC-delta signaling.
  • AGER1 plays a crucial protective role by suppressing AGE-induced ROS generation, highlighting its potential as a therapeutic target in vascular diseases associated with oxidative stress.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...